As China's Anti-monopoly Laws Go Into Effect, Rigorous Enforcement Could Apply To Deals On The Table
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - New regulations that took effect this week help clarify a year-old Anti-monopoly Law in China but may be a prelude to more active enforcement by local authorities
You may also be interested in...
What Does China's Price Manipulation Ruling On Unilever Mean For Global Pharma? (Part 2 of 2)
[Editor's note: This is part two of a two-part feature; part one covered the background of China's National Development and Reform Commission charge against consumer goods company Unilever and what multinational companies operating in China should take away from the incident. This second part looks at the larger impact of China's inflation on pharma companies.]
What Does China's Price Manipulation Ruling On Unilever Mean For Global Pharma? (Part 2 of 2)
[Editor's note: This is part two of a two-part feature; part one covered the background of China's National Development and Reform Commission charge against consumer goods company Unilever and what multinational companies operating in China should take away from the incident. This second part looks at the larger impact of China's inflation on pharma companies.]
Novartis Tagged With Anti-monopoly Conditions In China For Alcon Acquisition
HONG KONG - China's growing assertiveness in commercial matters is becoming evident in its influence on merger and acquisitions matters and its willingness to impose conditions under its two-year-old anti-monopoly law